⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 15, 2024Open Access

Successful treatment of refractory prurigo nodular with abrocitinib

View Full Paper

Ask AI

Bookmark

Share

Abstract

Successful treatment of refractory prurigo nodularis with abrocitinibFang Sun1, Zhenzhen Wu11 Derpartment of Dermatology, Affiliated AoYang Hospital of Jiangsu University, Zhangjiagang, Jiangsu, ChinaCorresponding author: Zhenzhen Wu, Derpartment of Dermatology, Affiliated AoYang Hospital of Jiangsu University, Zhangjiagang, Jiangsu, ChinaZhangjiagang 222 Gangcheng Road, Jiangsu, China, E-mail: 19951236675 @163.com

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Sun et al. (2024) studied this question.

synapsesocial.com/papers/68e73ec2b6db6435876b7e68 https://doi.org/10.22541/au.171052387.75008130/v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Successful treatment of refractory prurigo nodularis with abrocitinib2024 · 13 citations
2Abrocitinib Monotherapy for Refractory Prurigo Nodularis: Report of Two Successful Cases2024 · 2 citations
3Clinical Outcomes of Abrocitinib in Prurigo Spectrum Disorders: A Case SeriesCase Report · 2026
4Successful treatment of prurigo nodularis with abrocitinib: A case report2024 · 3 citations
5Targeting the JAK-STAT pathway: Successful use of abrocitinib in refractory prurigo nodularisMeta-Analysis · 2026 · 1 citations